WILTERDING MARK (Chief Financial Officer) sold 23.7% of their position (7.76K shares) of RXSIGHT, INC. on the open market
Open‑market sale worth $54.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0001193125-26-380713
Officer· Chief Financial Officer
Since Feb 2026
-7.76K
Net shares
Net seller
$54.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.44K acquired · 28.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.44K
Price / share
—
Trade value
—
% of position
165.2%
8/31/2026
12.37K→32.81K
Common Stock
Direct
Shares
−7.76K
Price / share
$6.96
Trade value
$54.04K
% of position
23.7%
9/2/2026
32.81K→25.05K
Total
Net shares
+12.68K
Net value
-$54.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2026 | M · Option Exercise | +20.44K | — | — | 165.2% | 12.37K | 32.81K |
| Common Stock Direct | 9/2/2026 | S · Sale | −7.76K | $6.96 | $54.04K | 23.7% | 32.81K | 25.05K |
| Total | +12.68K | -$54.04K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
20.44K shares
Shares
−20.44K
Strike price
Held after
122.65K
Exercisable
—
8/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock20.44K shares | 8/31/2026 | M · Option Exercise | −20.44K | — | 122.65K |